Keyword: Harvard Medical School

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.

Researchers at Rejuvenate Bio say they have compelling evidence that gene therapy could treat diabetes, obesity, and heart and kidney failure.

Buzzy biotech Moderna is to use its mRNA tech to “explore fundamental immunological processes” with researchers at Harvard.

TScan aims to uncover new targets for T-cell therapies and bring them to more patients with both solid tumors and blood cancers.

The week’s biotech news included positive results from a study of Merck’s Cavatak in bladder cancer and the use of CRISPR to reverse genetic deafness.

Twentyeight-Seven will ramp up its cancer programs, develop programs aimed at other types of RNA and apply its work in non-oncology disease areas.

Semma and Harvard scientists are reporting they've figured out how to regenerate high quantities of insulin-producing beta cells.

The Harvard researcher who first discovered the "exercise hormone" irisin reports it may be useful in bone formation.

The gift will enable Harvard to set up an incubator for biotech startups and invest in its research capabilities. 

A rare cell type, discovered by two teams and named as "pulmonary ionocyte," appears to help drive cystic fibrosis.